William Blair Downgrades Amgen to "Market Perform" (AMGN)

William Blair Downgrades Amgen to “Market Perform” (AMGN)


Biotech giant Amgen, Inc. (AMGN) was downgraded by analysts at William Blair on Tuesday, as the company may be in store for a transitional year in 2013.

The analysts downgraded AMGN from “Outperform” to “Market Perform.”

Amgen shares were down slightly during morning trading on Tuesday. The stock is up about +26% over the past year.

The Bottom Line
Shares of Amgen, Inc. (AMGN) have a dividend yield of 2.23% based on Tuesday’s intraday trading price of $84.43 and the company’s annualized dividend payout of $1.88 per share.

Amgen, Inc. (AMGN)is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today